Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development.
Sep 9, 2015
Citi 10th Annual Biotech Conference
Nov 9, 2015
2015 Credit Suisse Healthcare Conference
Nov 16, 2015
Brean Capital 2015 Life Sciences Summit